seed
Stage
1
Investors
About
Ischemia Care develops and commercializes a stroke blood testing platform that uses RNA expression and artificial intelligence to provide clinicians with accurate stroke diagnosis and cause differentiation, improving patient care and reducing hospital costs.
Explore Ischemia Care's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.